ACM Global Central Laboratory, the central laboratory that continually defines the customer-service standard with its flexible approach, has relocated its laboratory facilities in York, England. The new, state-of-the-art facility offers 14,500 square feet of laboratory and office space, nearly twice the size of ACM Global’s previous facility in York, and accommodates ACM Global’s expanding laboratory operations as well as its growing staff of data analysts, project managers and quality assurance specialists.

The move to a larger facility is in response to growing client demand for ACM Global’s clinical trials testing services throughout Europe, including Western and Eastern Europe, as well as South Africa and the middle East.

“Our new facility enables us to continue our growth in the European market and to expand the menu of clinical trials testing services we offer our clients,” said Jerry Boxall, managing director, Europe at ACM Global Central Laboratory. “We are excited with the prospects offered by our new facility, which has been purpose-built to optimize our laboratory processes. The additional space enhances our ability to continue to meet the needs of our clients with high-quality laboratory services, while positioning us to take advantage of new opportunities in the market.”

“Expansion of our European laboratory hub represents a significant investment by our company, driven by our growth over the last several years”, said Angela J Panzarella, president of ACM Medical Laboratory, Incorporated, the parent company of ACM Global Central Laboratory. “We have enjoyed robust growth in our European and global business, and the new facility represents our commitment to the region and to continuous improvement of the services we offer our clients.”

ACM Global's new laboratory will be inaugurated on January 17, 2013. Current and prospective clients are invited to attend the event, which includes a day-workshop.

ACM Global Central Lab offers a flexible approach and a focus on precision to optimize the clinical study outcomes for our clients. ACM Global performs 20 million diagnostic tests each year, offering more than 1,500 individual assays spanning virtually all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics.